ESMO data illuminate APG-157’s immune-modulating mechanism in Head and Neck Cancer ahead of the upcoming Phase 3 trial and its broad therapeutic potential BEDFORD, MA, UNITED STATES, October 13, 2025 /⁨EINPresswire.com⁩/ -- Aveta Biomics, a clinical-stage …